Related Experiment Video
Updated: Mar 13, 2026
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
[Expression Level of S100A6 mRNA in MM and Its Clinical Significance]
Hong-Yu Bao1, Jian-Nin Wang1, Qing-Qi Meng1
1Department of Hematology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China.
Objective:
To investigate the expression level of S100A6 mRNA in MM and to its clinical significance, and to evaluate its significance.
Methods:
The expression level of S100A6 mRNA in MM patients was determined by real time quantitative PCR(RQ-PCR), and its relationship with the clinical features and outcomes of patients was analyzed by statistic method.
Results:
S100A6 mRNA was detected in 20 MM patients. Compared with normal persons, the S100A6 mRNA expression in MM patients was higher. In different groups, the S100A6 mRNA expression in MM patients of 3 stages was higer than that in patients of 1 and 2 stages. MM patients with higher S100A6 mRNA expression had poor prognosis and higer extramedullary metastasis rate.
Conclusion:
The high expression of S100A6 mRNA is associated with poor prognosis and may be a prognostic molecular marker of MM.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018